【引用本文】王 权，李 爽. 免疫治疗时代Ⅳ期胃癌转化治疗方案选择[J]. 中国实用外科杂志,2024,44(10):1129-1133.  摘要 ...

We compared the gene expression patterns of oxaliplatin-resistant cell lines with the patterns of their sensitive counterparts in an attempt to discover universal mechanisms that characterize ...

All medicines have risks and benefits. Your doctor has weighed the risks of you using oxaliplatin against the benefits they expect it will have for you. If you have any concerns about taking this ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnology company working to develop the world's most potent vaccines, ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.

The global burden of digestive tract tumors is profound, with these cancers accounting for nearly half of all malignant ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2 Long COVID Results Expected Soon Dogwood Therapeutics, Inc.

Ferroptosis offers new strategies to combat treatment resistance in digestive tract cancers, enhancing the efficacy of ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

These include the taxanes, such as paclitaxel, often used to treat breast, ovarian, prostate and lung cancers; as well as alkylating agents, including oxaliplatin, used to treat colorectal, stomach or ...